Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Enforcement

Warning Letters Week Of 11/1/2020: Hold Times

No items found.
Enforcement

Warning Letters Week Of 10/25/2020: Cleaning Validation

No items found.

An Update On 503B Outsourcing Facilities

No items found.
Enforcement

Warning Letters Week Of 10/18/2020: Misbranded Biologics

No items found.

Data Integrity 101: Why is it Important?

No items found.

On-Demand Webinar | Russian, UK, and US Top Ten Pharma Inspection Findings FY 2019

No items found.
Enforcement

Warning Letters Week Of 10/11/2020: Unauthorized Cell Therapy

No items found.
Enforcement

Warning Letters 10/4/2020: Medical Device Adverse Events

No items found.
Enforcement

Q2 2020 Food and Dietary Supplement Warning Letters

No items found.
Enforcement

Warning Letters Week Of 9/27/2020: Aseptic Process Issues

No items found.
Enforcement

Warning Letters Week Of 9/20/2020: Quality Unit Failures

No items found.

Instant Download | A Look at Virtual Inspections

No items found.

How are Medical Device Trials Different?

No items found.
Enforcement

Warning Letters Week Of 9/13/2020: Lack of Validation

No items found.

On-demand Webinar | CMC Considerations for CGT Products

No items found.

Embrace Change to Build A Mature Quality Culture

No items found.
Enforcement

Highlights from Recent FDA Inspections of Vendors/Suppliers

No items found.
Enforcement

Warning Letters Week Of 9/6/2020: Data Integrity Failures

No items found.